EW:BMV
Edwards Lifesciences Corp
MX$1,465.83
arrow_upward
+0.62%(+9.06) 1D
Jul 28, 2:00:00 PM GMT-6 · MXN
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
MX$1,465.83
High
MX$1,465.83
Low
MX$1,465.83
Mkt. cap
48.18B
Avg. vol.
54.00
Volume
12.67K
52-wk high
MX$1,656.20
52-wk low
MX$1,340.70
Shares outstanding
209.05M
No. of employees
16K
Open
MX$1,465.83
High
MX$1,465.83
Low
MX$1,465.83
Mkt. cap
48.18B
Avg. vol.
54.00
Volume
12.67K
52-wk high
MX$1,656.20
52-wk low
MX$1,340.70
Shares outstanding
209.05M
No. of employees
16K
News stories
From sources across the web
Stock Titan
·
3 hours ago
Edwards Lifesciences (NYSE: EW) planned resale of 818,958 shares disclosed
TipRanks
·
21 hours ago
Top Executive Cashes In on Major Edwards Lifesciences Stock Move
Investing.com Canada
·
23 hours ago
Form 4 Edwards Lifesciences Corp For: 27 July By Investing.com
Investing.com
·
1 day ago
Edwards Lifesciences CEO Bernard Zovighian sells $245,134 in shares
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com
AI content may include mistakes. Learn more